← All patents

US20210062274A1

Molecular subtyping of small cell lung cancer to predict therapeutic responses

University of Texas System

Abstract

Provided herein are methods for determining a subtype of a small cell lung cancer in a patient based on the express status of ASCL1, NEUROD1, and POU2F3, which are expressed in a mutually exclusive fashion. The subtype of the cancer can be used to determine the sensitivity of the cancer to certain …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Carl M. GAY
Priority date
September 03, 2019
Filing date
September 03, 2020
Publication date
March 04, 2021
Language
en
Metadata fetched
August 29, 2026 00:28